Hiroya Takeoka

676 total citations
28 papers, 193 citations indexed

About

Hiroya Takeoka is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Hiroya Takeoka has authored 28 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Nephrology and 5 papers in Surgery. Recurrent topics in Hiroya Takeoka's work include Renal Diseases and Glomerulopathies (4 papers), Dialysis and Renal Disease Management (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Hiroya Takeoka is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Dialysis and Renal Disease Management (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Hiroya Takeoka collaborates with scholars based in Japan and United States. Hiroya Takeoka's co-authors include Noriyuki Iehara, Mari Tanaka, Toru Kita, Masaaki Sunamoto, Toshio Doi, Yoshihiko Yamada, Kogo Kuze, Kazuhiro Nagata, Kojiro Yamamoto and Keisuke Taniguchi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and The Journal of Pathology.

In The Last Decade

Hiroya Takeoka

23 papers receiving 188 citations

Peers

Countries citing papers authored by Hiroya Takeoka

Since Specialization

Citations

This map shows the geographic impact of Hiroya Takeoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroya Takeoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroya Takeoka more than expected).

Fields of papers citing papers by Hiroya Takeoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroya Takeoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroya Takeoka. The network helps show where Hiroya Takeoka may publish in the future.

Co-authorship network of co-authors of Hiroya Takeoka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroya Takeoka. A scholar is included among the top collaborators of Hiroya Takeoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroya Takeoka. Hiroya Takeoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osmotic nephropathy as a potentially underrecognized cause of acute kidney injury during SGLT2 inhibitor therapy: a case report and literature review 2026 ·CEN Case Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroya Takeoka	0
2	Hypereosinophilia-associated acute intradialytic hypotension: a report of three cases and literature review 2024 ·CEN Case Reports ·(unknown), Mari Tanaka, (unknown), (unknown), Hiroko Yamamoto, (unknown), (unknown), (unknown), (unknown), Kotaro Maeda, (unknown), (unknown), (unknown), Hiroya Takeoka	0
3	Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review 2023 ·CEN Case Reports ·(unknown), Mari Tanaka, Hiroko Yamamoto, (unknown), (unknown), (unknown), Kotaro Maeda, (unknown), (unknown), (unknown), (unknown), Hiroya Takeoka	2
4	Rapidly progressive IgA vasculitis-associated nephritis successfully treated with immunosuppressive therapy in an adolescent with chronic granulomatous disease 2021 ·CEN Case Reports ·Mari Tanaka, Keisuke Taniguchi, (unknown), (unknown), (unknown), Masafumi Hasui, Hiroya Takeoka	3
5	A case of septic pulmonary embolism caused by P. aeruginosa in a hemodialysis patient and review of the literature 2020 ·Renal Replacement Therapy ·(unknown), Mari Tanaka, (unknown), (unknown), Kotaro Maeda, (unknown), (unknown), Keisuke Taniguchi, (unknown), (unknown), Hiroya Takeoka	1
6	The effectiveness of a specialized team intervention on prognosis in patients undergoing continuous renal replacement therapy: A retrospective cohort study 2020 ·Clinical Nephrology ·(unknown), Yuki Kataoka, (unknown), Hiroya Takeoka	0
7	Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function 2019 ·CEN Case Reports ·(unknown), Mari Tanaka, (unknown), (unknown), (unknown), (unknown), Keisuke Taniguchi, (unknown), (unknown), Hiroya Takeoka	14
8	Clinicopathological features of progressive renal involvement in TAFRO syndrome 2017 ·Medicine ·Mari Tanaka, Hiraku Tsujimoto, Kojiro Yamamoto, (unknown), Kazumasa Oka, Hiroya Takeoka	19
9	Advanced Glycosylation End Products Modulate Transcriptional Regulations on Mesangial Cells 2015 ·Contributions to nephrology ·Noriyuki Iehara, Hiroya Takeoka, Hiroko Tsuji, Yasumasa Yamada, Tomo Kita, Toshio Doi	0
10	Preeclampsia before 20 weeks of gestation: a case report and review of the literature 2014 ·CEN Case Reports ·Mari Tanaka, Yasushi Tsujimoto, Kimihiko Goto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroshi Satō, Masaya Hirose, Hiroya Takeoka	17
11	Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report 2010 ·Journal of Medical Case Reports ·Toshikazu Araoka, Hiroya Takeoka, Keisuke Nishioka, (unknown), (unknown), (unknown), Seiji Kishi, Makoto Araki, (unknown), Taichi Murakami, Akira Mima, Kojiro Nagai, Hideharu Abe, Toshio Doi	3
12	Safety and efficacy of interferon-beta therapy for hemodialysis patient with HCV 2009 ·Nihon Toseki Igakkai Zasshi ·Toshikazu Araoka, Hiroya Takeoka, Keisuke Nishioka, Seiji Kishi, Makoto Araki, Fumi Kishi, (unknown), Taichi Murakami, Naoki Kondo, Motokazu Matsuura, Kazuhiro Yoshikawa, Akira Mima, Kojiro Nagai, Toshikazu Takahashi, Hideharu Abe, Masaki Ikeda, Makiko Kondo, Azusa Sugiyama, Masahiko Sugano, Toshio Doi	3
13	Effects of weekly intravenous administration of darbepoetin alpha (NESP) for one year on renal anemia and medical economics in hemodialysis patients 2009 ·Nihon Toseki Igakkai Zasshi ·(unknown), Takashi Okumura, Hiroya Takeoka, Keisuke Nishioka, Masaki Ikeda, Makiko Kondo, Masaaki Izumi, (unknown), (unknown), (unknown), Megumu Fukunaga, Susumu Oseto	1
14	The efficacy of darbepoetin alfa for treating anemia, when administered intravenously once weekly: Hemodialysis patients (n=157) maintained on recombinant human erythropoietin were switched to darbepoetin alfa 2008 ·Nihon Toseki Igakkai Zasshi ·(unknown), Takashi Okumura, Hiroya Takeoka, Keisuke Nishioka, Susumu Oseto, (unknown), Megumu Fukunaga	2
15	A case of pancytopenia in a hemodialysis patient due to tuberculosis-associated hemophagocytic syndrome 2007 ·Nihon Toseki Igakkai Zasshi ·Makoto Araki, Keisuke Nishioka, Seiji Kishi, Toshikazu Araoka, (unknown), Sachiko Yamamoto, Masaki Ikeda, (unknown), (unknown), (unknown), Hiroya Takeoka	1
16	IgM-immune complex glomerulonephritis associated with sarcoidosis 2006 ·Clinical and Experimental Nephrology ·Hiroshi Kanamori, (unknown), Hiroya Takeoka, Kenji Osafune, (unknown), Atsushi Fukatsu, Kazuro Kanatsu	7
17	Expression of heat shock protein 47 is increased in remnant kidney and correlates with disease progression 1998 ·International Journal of Experimental Pathology ·Masaaki Sunamoto, Kogo Kuze, Noriyuki Iehara, Hiroya Takeoka, Kazuhiro Nagata, Toru Kita, Toshio Doi	36
18	A Multifunctional Transcription Factor (A1p145) Regulates the Smooth Muscle Phenotype in Mesangial Cells 1998 ·Biochemical and Biophysical Research Communications ·Hiroya Takeoka, Noriyuki Iehara, (unknown), Hideharu Abe, Masaaki Sunamoto, Yoshihiko Yamada, Toru Kita, (unknown)	8
19	A novel transcription factor is correlated with both glomerular proliferation and sclerosis in the rat renal ablation model 1997 ·The Journal of Pathology ·Kogo Kuze, Masaaki Sunamoto, (unknown), Noriyuki Iehara, Hiroya Takeoka, Yoshihiko Yamada, Toru Kita, Toshio Doi	5
20	Differentiation of smooth muscle phenotypes in mouse mesangial cells 1996 ·Kidney International ·Noriyuki Iehara, Hiroya Takeoka, Hiroko Tsuji, (unknown), Douglas N. Foster, Arthur R. Strauch, Yoshihiko Yamada, Toru Kita, Toshio Doi	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact